Clinical trial

Androgen Effect on Klinefelter Syndrome Motor Outcome

NCT00348946 · Thomas Jefferson University, Other · Completed

Key facts

NCT number NCT00348946
Title Androgen Effect on Klinefelter Syndrome Motor Outcome
Official title Androgen Effect on Motor/Cognitive Outcome in Klinefelter Syndrome
Lead sponsor Thomas Jefferson University, Other
Collaborators National Institute of Neurological Disorders and Stroke (NINDS) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Klinefelter Syndrome
Intervention type Drug, Other
Interventions androgen oxandrolone, placebo
Enrollment 93
Start date Jul 1, 2006
Primary completion Nov 30, 2017
Completion Nov 30, 2017
First posted Jul 6, 2006
Last update posted Jul 8, 2021
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies